| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Jun 16, 2016 |
|||||||||
| Q1 FY17 | $0.70 | $0.69 | $34.60B | $34.11B |
NYSE |
||||
| Q4 FY16 | $0.81 | $0.81 | $10.59B | $10.72B |
NYSE |
||||
|
Smith & Wesson Brands
SWBI
|
Q4 FY16 | $0.66 | $0.54 | $221.12M | $171.98M |
NASDAQ |
|||
|
Sonoma Pharmaceuticals
SNOA
|
Q4 FY16 | -$36.73 | - | $3.53M | - |
NASDAQ |
|||
|
Moleculin Biotech
MBRX
|
- | -$111.27 | - | - | - |
NASDAQ |
|||
